NCT05384769View on ClinicalTrials.gov

Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

July 29, 2022

Primary Completion Date

January 28, 2029

Study Completion Date

January 28, 2029

Conditions
Lung Carcinoma
Interventions
PROCEDURE

Liquid Biopsy

Undergo liquid biopsy

PROCEDURE

Low Dose Computed Tomography of the Chest

Undergo low dose CT

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER